Rate My Professor Christopher Chapman

Chapman's research specializations centre on the development and clinical translation of bioelectronic implants for cancer therapeutics and monitoring. His work encompasses bioelectronics design and fabrication for central and peripheral nervous system applications using conducting polymers and metals via laser-based and traditional microfabrication. Key interests include localized electrical and pharmaceutical therapies, tumour microenvironment diagnostics, organ-on-a-chip platforms, cancer neuroscience, electrical stimulation and recording, and multifunctional materials. He leads the CARClab within the Centre for Bioengineering. Notable funding includes £403,666 from ARIA for 'Oligodendronics: Engineering biology for scalable neural interfaces' (2025-2026), £74,990 from Barts and the London Charity for 'Development of multimodal tumour margin detection paradigm for use in neurosurgical oncology' (2025-2026), and £20,000 from the Royal Society for 'Customizable conducting elastomers for bioelectronics sensors' (2024-2025). His influential publications feature 'Nanoporous Gold as a Neural Interface Coating: Effects of Topography, Surface Chemistry, and Feature Size' (ACS Applied Materials & Interfaces, 2015), 'Mind the gap: State-of-the-art technologies and applications for EEG-based brain-computer interfaces' (APL Bioengineering, 2021), 'Electroactive Polymers for On-Demand Drug Release' (Advanced Healthcare Materials, 2024), and 'Stretchable, fully polymeric electrode arrays for peripheral nerve stimulation' (Advanced Science, 2021), contributing significantly to neural interfaces, drug delivery, and oncology applications.